尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Rucker Michael A., 董事. Officer active across 4 companies, notably MEDNAX, INC.. Aggregated, 9 disclosures have been published. Split: 0 buy · 2 sells. Total volume traded: €207k. History available since 12 May 2021. The latest transaction was disclosed on 12 August 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 条申报中的 9 条
Michael A. Rucker is a Director at MEDNAX, INC. In this role, he contributes to the strategic direction of the company and oversees its operations. His expertise in the healthcare sector is essential for guiding Mednax's strategic decisions.